جست‌وجوی استاد و پژوهشگر

Peter Tessarzمشاهده پروفایل

پژوهشگر

• Chromatin Biology
• Epigenetics
• Cellular Aging
• +۳ مورد دیگر

Peter Tessarz is a Research Group Leader at the Radboud Institute for Molecular Life Sciences (Nijmegen, Netherlands), focusing on chromatin structure, epigenetics, and aging. His lab relocated from the Max Planck Institute for Biology of Ageing (Cologne, Germany), where he led the Max Planck Research Group Tessarz since 2014. Research interests include how chromatin architecture regulates gene expression during aging, with a focus on age-related epigenetic changes, metabolic-chromatin interactions, inter-organellar communication, and transcriptional control. His group employs S. cerevisiae , cell culture systems, primary cells, and advanced sequencing technologies. Recent publications highlight his work on hypoxia's role in osteogenesis, chromatin remodeling in aged stem cells, H2A methylation, and the metabolism-epigenetics axis. Scientific awards include two Kekulé Fellowships (2004, 2014). Third-party funding includes grants from the Marga and Walter Boll Foundation (2022-2024), BMBF Research Consortium IDEpiCo (2021-2024), DFG Research Grant (2017-2020), and others. Lab members include researchers like Chrysa Nikopoulou and Monika Maleszewska.

Stefan Strickerمشاهده پروفایل

استاد

• CRISPR-based epigenetic engineering
• Neural stem cells
• Brain tumours
• +۳ مورد دیگر

Prof. Dr. Stefan Stricker is a full member of the Graduate School of Systemic Neurosciences (GSN) and a regular member of the Munich Center for Neurosciences (MCN) at Ludwig-Maximilians-Universität München (LMU). He leads the Physiological Genomics research group jointly housed at the Biomedical Center LMU and Helmholtz Zentrum München, where he explores CRISPR-based epigenetic engineering, neural stem cell biology and brain tumour reprogramming. Research Interests: CRISPR-based epigenetic engineering – developing precise tools to rewrite chromatin states in somatic and cancer cells. Neural stem cell identity – decoding transcriptional and epigenetic networks that govern self-renewal versus differentiation. Brain tumour reprogramming – converting malignant glioma cells to a pluripotent, non-tumourigenic state to interrogate cancer epigenetics. Long non-coding RNAs (lncRNAs) – investigating Airn and other macro ncRNAs in genomic imprinting and gene-silencing mechanisms. Across more than fifteen years his work has produced a coherent body of literature that moves from fundamental imprinting biology in embryonic stem cells to translational applications in glioblastoma. Re-occurring themes include DNA-methylation resetting, allele-specific expression biases, and the therapeutic vulnerabilities of glioblastoma initiating cells. Selected Publications & Trends: The 15 most recent publications (2004-2014) reveal a clear progression from mechanistic studies of lncRNA-mediated silencing ( Airn , Igf2r ) to high-impact investigations of glioblastoma stem-cell biology and CRISPR-mediated reprogramming. Collectively these works sit at the intersection of epigenetics , cancer biology and neurodevelopment . Scientific Awards & Fellowships: While no specific prizes are listed, multiple papers were recommended or highlighted by Faculty of 1000 and featured research highlights in Cancer Research and Nature Reviews Cancer . Advising & Training: Graduated GSN student: Dr. Valentin Baumann Laboratory & Institutional Affiliations: Prof. Stricker’s Physiological Genomics group is physically embedded within the Biomedical Center LMU and the Helmholtz Zentrum München, facilitating close collaboration between the university medical faculty and Germany’s largest biomedical research organisation.

• Neurobehavioral Research
• Cognitive Function
• Addiction
• +۷ مورد دیگر

Edward Daniel Levin is Professor in Psychiatry and Behavioral Sciences at Duke University School of Medicine, with secondary appointments in Psychology and Neuroscience, Pharmacology & Cancer Biology, and the Nicholas School of the Environment. He serves as Chief of the Neurobehavioral Research Lab in the Psychiatry Department and maintains affiliations with the Duke Institute for Brain Sciences, Duke Cancer Institute, and Duke Initiative for Science & Society. Dr. Levin earned his Ph.D. from the University of Wisconsin, Madison in 1984. His research spans three interconnected domains: basic neurobiology of cognition and addiction, neurobehavioral toxicology, and development of novel therapeutic treatments for cognitive dysfunction and substance abuse. His laboratory employs both rodent and zebrafish models to investigate neural mechanisms underlying cognitive processes. Dr. Levin's work has consistently focused on nicotine's effects on learning, memory, and attention, with particular emphasis on alpha7 and alpha4beta2 nicotinic receptor subtypes in the hippocampus, amygdala, thalamus, and frontal cortex. His research examines interactions between these receptors and dopamine D1/D2 and glutamate NMDA systems. He has documented nicotine's memory-enhancing effects in both normal rats and those with specific brain lesions, and has conducted human studies assessing nicotine effects in schizophrenia, Alzheimer's Disease, and ADHD. His recent publications reveal an expanding focus on developmental neurotoxicology, particularly examining transgenerational effects of environmental contaminants including pesticides, flame retardants, heavy metals, and cannabis. His research demonstrates how basic neuroscience findings inform toxicology studies and vice versa, creating a powerful translational research approach with significant public health implications. Dr. Levin's laboratory represents a sophisticated integration of basic neuroscience, pharmacology, environmental health, and clinical applications. His work has been featured in media coverage on topics including climate change effects on the brain, decision-making research, and ADHD connections to secondhand smoke exposure.

Pelin Cayirlioglu Volkanمشاهده پروفایل

دانشیار

• Neurobiology
• Molecular Biology
• Genetics
• +۴ مورد دیگر

Pelin Cayirlioglu Volkan is an Associate Professor of Biology at Duke University, with additional appointments in Neurobiology and Cell Biology. She is also an Investigator in the Duke Institute for Brain Sciences. Education: Ph.D. in University of North Carolina, Chapel Hill (2003); M.S. and B.S. in Biology from Bogazici University (Turkey). Her research focuses on understanding how social experiences and pheromone signaling reshape gene expression, neural circuits, and behavior in Drosophila melanogaster . Her lab employs genetic tools, circuit-mapping techniques, and systems-level molecular analysis to explore: How social isolation affects the Drosophila brain and behaviors; Gene-circuit-behavior interconnections; Neurogenetic and epigenetic mechanisms in olfactory systems; Chromatin-level reprogramming of courtship regulators. Her recent publications highlight chromatin dynamics, pheromone-dependent gene regulation, and technical advancements in ChIP protocols for Drosophila neural tissues. Key trends include social experience-dependent epigenetic changes, axon terminal organization via cadherins, and rare-codon mRNA translation in neurons. Scientific Awards: Distinguished UNC Alumnus Award, UNC-CH (2013) She has received grants including the Neurobiology Training Program (2024-2029), Regulation of fertility by codon usage (2024-2029), and Epigenetic reprogramming of behaviors (2018-2024), reflecting her interdisciplinary approach to Drosophila social behavior and neural development.

Jeannine Gerhardtمشاهده پروفایل

دانشیار

• DNA Replication
• Genomic Stability
• Stem Cell Biology
• +۷ مورد دیگر

Dr. Jeannine Gerhardt is an Associate Professor of Stem Cell Biology at the Weill Cornell Medical College , affiliated with the Department of Obstetrics and Gynecology and the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine. Her research focuses on DNA replication dynamics, genomic stability, and repeat expansion disorders in human stem cells. Education : Master in Biochemistry (Friedrich Schiller University), PhD in Molecular Biology (Ludwig Maximilian University) Her work investigates how replication defects in stem cells with BRCA1/BRCA2 mutations or fragile X/Friedreich’s ataxia repeat expansions contribute to cancer predisposition and ovarian insufficiency. Using SMARD (single-molecule analysis of replicated DNA), her lab identified replication fork stalling and error-prone repair mechanisms as key drivers of genomic instability. Current studies aim to develop therapeutic strategies targeting these defects. Recent Publications highlight mechanisms in DNA replication timing, actin cytoskeleton dysregulation in fragile X oocytes, and FANCD2 recruitment to fragile sites. Her lab collaborates with researchers in reproductive medicine, cancer biology, and neurogenetics. Grants include NIH awards: P30 HD071593 (Reproductive Medicine) and R01 NS081366 (Neurogenetic Disorders). Lab members include postdoctoral associates, research associates, and technical staff specializing in stem cell culture and SMARD methodology.

Sue Hammoudمشاهده پروفایل

دانشیار

• Genetics
• Genomics
• Developmental Genetics
• +۳ مورد دیگر

Sue Hammoud is an Associate Professor at the University of Michigan Medical School in the Department of Human Genetics and Obstetrics and Gynecology. Her research focuses on reproductive genetics, epigenetics, and gametogenesis, particularly investigating molecular mechanisms in spermatogenesis and oocyte development. Key Research Areas: Epigenetic inheritance, chromatin dynamics in gametes, protamine function in sperm, and single-cell transcriptomics of reproductive tissues. Recent Work: Explores histone retention patterns, centromere symmetry restoration in zygotes, and cryopreservation effects on oocyte transcriptomes. Scientific Recognition: Recipient of the Judges' Choice Award in Therapeutics at the Equalize Startups Pitch Event for her translational research.

• B-cell lymphomas
• Germinal center immunology
• Cancer metabolism
• +۳ مورد دیگر

Dr Coraline Mlynarczyk is an Assistant Professor of Medicine (Hematology) at Yale School of Medicine, jointly appointed in Pathology and a member of Yale Cancer Center’s Center of Molecular and Cellular Oncology. Since launching her laboratory in July 2024, she has been dissecting how germinal-center B cells acquire malignant super-competitiveness, focusing on the lethal biology of relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Education PhD, Hematology & Oncology – Paris Diderot University & Saint-Louis Hospital, France MS, Molecular & Cellular Biology – University Pierre and Marie Curie, France MS, Biology/Health – Stockholm University, Sweden BS, Cellular Biology/Physiology – University of Burgundy, France Research Focus Her laboratory integrates multi-allelic mouse genetics , patient-derived tumor models , metabolic flux analyses , and single-cell immunological approaches to decode how aberrant cell-cell communication, metabolic fitness, and transcriptional rewiring drive aggressive B-cell transformation. Three guiding questions frame the program: Which extracellular signals endow B cells with competitive fitness and promote dissemination to immune-privileged sites? How do malignant B cells satisfy extreme metabolic demands for rapid proliferation? What biochemical mechanisms underlie elevated biosynthetic potential in competitive B cells? Funding & Awards Current research is supported by: American Cancer Society (ASPIRE Award) Mark Foundation for Cancer Research Follicular Lymphoma Foundation Yale University Institutional Research Grant (Pilot Award) Scientific Recognition Mark Foundation & Follicular Lymphoma Foundation Scholar Award (2024) American Cancer Society ASPIRE Award (2024) Lymphoma Research Foundation Fellow-to-Faculty Scholar Award (2020) American Society of Hematology Research Restart Award (2020) Laboratory & Team The Mlynarczyk Lab is housed on the 6th floor of 300 George Street, New Haven, CT, with dedicated wet-lab, imaging, and computational workspaces. The team uses state-of-the-art germinal-center reconstitution models, high-dimensional flow cytometry, metabolic flux analyzers, and single-cell RNA-seq to interrogate lymphoma evolution and therapeutic vulnerabilities.

Päivi M Ojalaمشاهده پروفایل

استاد

• Cancer Biology
• Virology
• Cellular Reprogramming
• +۶ مورد دیگر

Päivi M Ojala serves as a Professor in the Department of Pathology at the University of Helsinki's Faculty of Medicine. She actively supervises doctoral programs in Integrative Life Science and Biomedicine while leading cutting-edge cancer research initiatives. Her research spans Cancer Biology , Virology , and Immunotherapy , with specialized focus on viral tumorigenesis, cancer metastasis mechanisms, and CAR T-cell therapy development. Key interests include lymphatic endothelial cell interactions in melanoma metastasis, Kaposi Sarcoma Herpesvirus pathogenesis, and glycosphingolipid-targeted immunotherapies for ovarian carcinoma. Recent publications reveal strong emphasis on translational immunotherapy, particularly CAR T-cell engineering for solid tumors. Her 2023-2025 work demonstrates expertise in GMP-compliant manufacturing, novel CAR spacer design, and targeting metastasis-promoting molecular axes like DLL4/Notch3/WNT5B. Current projects include: Syöpäsäätiö-funded cancer research (2024-2025) Veripalvelu collaborations on CAR T-cell development (2023-2024) Gertrude Biomedical partnership for translational oncology As supervisor for doctoral programmes and frequent thesis pre-examiner/opponent, she actively shapes next-generation researchers. Her 49 documented academic activities include international collaborations with Imperial College London and extensive peer review contributions.

Tomokazu Kawashimaمشاهده پروفایل

دانشیار

• Plant Reproductive Development
• Molecular and Cellular Biology
• Plant Genetics
• +۳ مورد دیگر

Dr. Tomokazu Kawashima (Tomo Kawashima) is an Associate Professor at the University of Kentucky's Martin-Gatton College of Agriculture, Food and Environment, Department of Plant and Soil Sciences. He earned his Ph.D. in Molecular, Cell, and Developmental Biology from the University of California (2009) and a B.S. from the University of Tsukuba (2002). His research focuses on the molecular and cellular mechanisms governing plant sexual reproduction, seed development, and cytoskeleton dynamics in flowering plants and land plant evolution. He pioneered real-time live-cell imaging methods to study fertilization processes in Arabidopsis thaliana, revealing F-actin's role in sperm nuclear migration and the evolutionary transition from microtubule to F-actin-based systems in land plants. Recent publications highlight his work on dehydrin protein interactions, peri-germ cell membranes, coenocytic endosperm dynamics, and gene silencing in pollen cells. His lab investigates how environmental factors like temperature influence seed growth and yield. Scientific awards include the National Science Foundation award for plant fertilization research and editorial board memberships at The Plant Cell Plant & Cell Physiology PLOS Genetics . He mentors graduate researchers and recruits undergraduate students for projects on plant reproduction.

Jonas Larssonمشاهده پروفایل

استاد

• Hematopoietic Stem Cell Biology
• Gene Therapy
• Molecular Medicine
• +۷ مورد دیگر

Jonas Larsson is a Professor and Research team manager at the Division of Molecular Medicine and Gene Therapy, Faculty of Medicine, Lund University. He also serves as Deputy dean at the Faculty of Medicine, and holds principal investigator positions at both the Lund University Cancer Centre (LUCC) and StemTherapy: National Initiative on Stem Cells for Regenerative Therapy. Additionally, he is a Professor at the WCMM-Wallenberg Centre for Molecular Medicine. His extensive academic roles demonstrate his significant leadership and research contributions across multiple prestigious institutions within Lund University. Dr. Larsson's research focuses on hematopoietic stem cell biology, gene therapy, and molecular medicine. His work spans cancer research, regenerative medicine, stem cell differentiation, and blood cell formation. He employs cutting-edge techniques including CRISPR/Cas9 gene targeting and RNA interference to investigate fundamental mechanisms governing stem cell behavior. His research has important implications for understanding hematopoietic disorders and developing novel therapeutic approaches for blood-related diseases and cancers. Analysis of his publication record reveals a strong emphasis on hematopoietic stem cell dynamics during regeneration, molecular mechanisms of blood cell formation, and therapeutic applications of gene editing technologies. His research spans both basic science investigations of stem cell biology and translational work with clinical applications, particularly in the areas of leukemia and stem cell transplantation. Dr. Larsson actively supervises multiple PhD students and leads several major research projects including 'Enhancing blood stem cell transplantation using a nanotechnology-based RNA delivery system' and 'Deciphering mechanisms regulating renewal and differentiation of hematopoietic stem cells.' His collaborative work extends across international boundaries as indicated by his external collaborations. His laboratory work is centered around the Division of Molecular Medicine and Gene Therapy at Lund University, with additional affiliations at the Lund University Cancer Centre and StemTherapy initiative. These positions provide him with comprehensive resources for conducting cutting-edge research in stem cell biology and molecular medicine across multiple collaborative platforms.

Lucas Pelkmansمشاهده پروفایل

استاد

• Quantitative Biology
• Systems Biology
• Single-Cell Biology
• +۵ مورد دیگر

Lucas Pelkmans is a Full Professor at the Department of Molecular Life Sciences at the University of Zurich. He leads the Pelkmans Lab, a multi-disciplinary research group focused on understanding how biological scales are crossed from single molecules to tissues. His lab develops quantitative and scalable experimental approaches combined with computational and statistical methods to study fundamental biological questions. His research interests center on quantitative cell biology, systems biology, and the study of membrane-less organelles through phase separation. Pelkmans' work explores how cells process information across different scales, with particular focus on single-cell heterogeneity, cellular decision-making, and the principles governing biological organization. His lab actively encourages researchers to develop both wet-lab and dry-lab skills to tackle complex biological problems. The Pelkmans Lab has produced numerous high-impact publications, particularly in the areas of single-cell analysis, membrane-less organelles, quantitative imaging, and systems biology. Recent work demonstrates strong trends toward multimodal data integration, advanced computational approaches for analyzing cellular states, and understanding phase separation phenomena across biological scales. The lab's publications frequently appear in top-tier journals including Nature, Science, and Cell. Scientific Awards: ERC Advanced Grant (2020) EMBO member (2015) ERC Consolidator (2015) Ernst Hadorn Foundation-endowed Chair (2010) European Young Investigator Award (2005) ETH Medal (2003) Pelkmans actively mentors PhD students and postdoctoral fellows, with his lab comprising researchers from diverse backgrounds including physics, chemistry, computer science, and biology. His teaching includes courses on quantitative and molecular systems biology, and systems dynamics in cell and developmental biology. The lab has received significant grant support, including multiple ERC grants, enabling their innovative research on cellular organization and scale-crossing phenomena. The Pelkmans Lab maintains a highly collaborative environment that emphasizes both individual brilliance and team support. They have developed innovative technologies such as iterative indirect immunofluorescence imaging (4i) for multiplexed protein mapping, which has applications in precision medicine. The lab's work bridges fundamental biological questions with technological innovation, creating new approaches for studying cellular organization across multiple scales.

Anton Wutzمشاهده پروفایل

استاد

• Epigenetics
• X chromosome inactivation
• Stem cell differentiation
• +۶ مورد دیگر

Anton Wutz is a Full Professor of Genetics at the Institute of Molecular Health Sciences within the Department of Biology at ETH Zurich. His research focuses on epigenetic regulation and cell identity control, particularly examining how the cell nucleus specifies different cell types in the body and how changes in cell identity are regulated during development. His educational background includes: PhD from Technical University of Graz (1997), with research conducted at the Research Institute of Molecular Pathology in Vienna, Austria Postdoctoral work with Rudolf Jaenisch at the Whitehead Institute for Biomedical Research in Cambridge, USA Group leader at the Research Institute of Molecular Pathology (2001-2009) Principal Investigator at the Wellcome Trust Centre for Stem Cell Research, University of Cambridge (2009-2013) Professor Wutz's research primarily investigates epigenetic mechanisms, with a particular focus on X chromosome inactivation and its role in development and disease. His laboratory has made significant contributions to understanding how chromatin architecture and nuclear organization regulate gene expression during cell differentiation. The group has pioneered the use of haploid embryonic stem cells for genetic screening approaches, enabling novel insights into epigenetic regulation. Their work bridges molecular biology, genetics, and developmental biology to uncover fundamental principles of cellular identity specification. Analysis of Professor Wutz's recent publications reveals a strong focus on X chromosome inactivation mechanisms, with particular attention to the Xist RNA and its associated protein complexes. His research spans multiple model systems including mouse embryonic stem cells, organoids, and in vitro gametogenesis models. Key themes include the role of phase separation in chromatin organization, the impact of chromosome dosage on cellular processes, and the connection between epigenetic regulation and disease mechanisms such as autoimmunity. His laboratory continues to develop innovative genetic tools for studying mammalian developmental pathways. Professor Wutz actively contributes to several educational programs at ETH Zurich, teaching courses in epigenetics, computational methods in genome analysis, and fundamental biology. His laboratory serves as a training ground for PhD students and postdoctoral researchers interested in epigenetics and developmental biology. Through collaborations with other research groups at ETH Zurich and internationally, his team maintains a strong research program exploring the fundamental mechanisms of epigenetic regulation. The Wutz laboratory operates within the Institute of Molecular Health Sciences at ETH Zurich, utilizing advanced molecular and cellular techniques to investigate epigenetic mechanisms. The group maintains active collaborations with other research teams both within ETH Zurich and internationally, fostering a dynamic research environment focused on understanding the molecular basis of cell identity regulation.

• Biochemistry and cell biology
• Genetics
• Clinical sciences
• +۲ مورد دیگر

Sanna Barrand is a Research Fellow at Deakin University's School of Health and Social Development under the Faculty of Health. Her work bridges molecular biology, epigenetics, and clinical sciences to explore the developmental origins of health and disease. Research Focus: Epigenetic mechanisms in stem cells, maternal diet impacts on offspring organ development, and transgenerational inheritance patterns. Key Collaborations: Works with teams studying cardiovascular and renal health programming, including collaborations with researchers like Davis JA, Collas P, and Wood-Bradley RJ. Publications: Recent studies examine in utero dietary effects on kidney and cardiac development, hypothalamic transcriptome changes, and epigenetic regulation in stem cells.

John Denuمشاهده پروفایل

استاد

• Epigenetics
• Metabolism
• Chromatin Remodeling
• +۷ مورد دیگر

John Denu is a Professor at the University of Wisconsin–Madison leading the Denu Laboratory, which is part of the Microbiome, Epigenetics, and Multi-omics hubs at the Wisconsin Institute for Discovery. His research program investigates the molecular connections between metabolism and epigenetic pathways in human health and age-associated diseases. The lab employs biochemical, genetic, and multi-omics approaches to study chromatin dynamics, utilizing mammalian tissue culture systems and mouse models. Denu's research interests center on understanding how metabolic pathways influence epigenetic regulation. His work focuses on three primary areas: the molecular links between metabolism and epigenetic pathways; the biochemical principles governing epigenetic information written onto histones; and the role of sirtuins in reversible protein acetylation. His lab explores how chromatin remodeling enzymes rely on metabolite-derived co-enzymes, suggesting coordination between nuclear events and metabolic networks. He investigates the hypothesis that chromatin modifying complexes have evolved to sense metabolite levels and respond accordingly. Analysis of his recent publications reveals a strong focus on metabolism-epigenome interactions, with particular emphasis on sirtuins, histone modifications, and the role of specific metabolites like citrate and short-chain fatty acids in regulating chromatin function. His work spans from fundamental biochemical mechanisms to disease-relevant models, particularly in neurodegeneration and aging. Denu mentors several graduate students including Jessica Han (who recently defended her PhD on diet, gut microbiome, and metabolism converging to remodel epigenetics) and Kellen Biesbrock (who joined in 2025). His lab actively collaborates with researchers across campus, including with Prof. Federico E. Rey in the Department of Bacteriology. The Denu Laboratory employs an interdisciplinary approach spanning basic biochemistry to big data, using methods ranging from in vitro enzyme assays to high-throughput mass spectrometry. The lab is actively involved in many collaborations both on and off campus, reflecting the integrative nature of metabolism-epigenome research.

Sayem Miahمشاهده پروفایل

استادیار

• Cell Signaling Networks
• Cancer Biology
• Proteomics
• +۴ مورد دیگر

Sayem Miah is an Assistant Professor at the University of Arkansas for Medical Sciences (UAMS), affiliated with the Winthrop P. Rockefeller Cancer Institute. He holds a B.Sc. from Rajshahi University (Bangladesh), M.Sc. from Linkoping University (Sweden), and Ph.D. from the University of Saskatchewan (Canada). His research focuses on cancer signaling networks, particularly the molecular mechanisms underlying tumorigenesis and metastasis in triple-negative breast cancer (TNBC), utilizing proteomic, biochemical, and genomic approaches. Education: B.Sc., Rajshahi University, Bangladesh M.Sc., Linkoping University, Sweden Ph.D., University of Saskatchewan, Canada Research in the Miah lab investigates how cells decode complex signals in health and disease states, with a focus on TGFβ/SMAD signaling paradox in metastasis. Key projects include defining BRK-regulated SMAD4 networks, mapping chromatin remodeling in TNBC, and identifying multi-target therapeutics against oncogenic non-receptor tyrosine kinases. The lab's recent publications (2010-2024) span topics including Sin3/HDAC complex dynamics, BRK's role in proteasomal degradation, EMT regulation via FRK, epigenetic reprogramming in metastasis, and methodological advances in proteomic analysis. These works emphasize signal transduction, chromatin biology, and precision oncology applications. Laboratory Contact: Office: 501-214-2455 ex 25234 Lab: 501-551-4293 Location: Winthrop P. Rockefeller Cancer Institute, Rooms 9109 (office) and 9152 (lab)